Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Phylum Chlamydiae

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Vaccinations

Vaccinations

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Microbes can capture carbon and degrade plastic - why aren't we using them more?

Nature·2025

Same author

Europe needs a sustainably funded influenza research and response network.

The Lancet. Infectious diseases·2025

Same author

State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens.

Seminars in respiratory and critical care medicine·2025

Same author

Discovery and characterization of a pan-betacoronavirus S2-binding antibody.

Structure (London, England : 1993)·2024

Same author

Transforming vaccinology.

Cell·2024

Same author

Scientists' call to action: Microbes, planetary health, and the Sustainable Development Goals.

Cell·2024

Search research articles

Related Experiment Video

Updated: May 14, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Chlamydia trachomatis control requires a vaccine.

Robert C Brunham¹, Rino Rappuoli

¹University of British Columbia and the British Columbia Centre for Disease Control, Vancouver, Canada. robert.brunham@bccdc.ca

|February 5, 2013

Summary

This summary is machine-generated.

Chlamydia trachomatis infections are rising due to reduced herd immunity from treatment programs. A Chlamydia vaccine is essential for effective control, with subunit vaccine candidates showing scientific feasibility.

More Related Videos

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis

Published on: January 30, 2020

Forward Genetic Approaches in Chlamydia trachomatis

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Related Experiment Videos

Last Updated: May 14, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis

Published on: January 30, 2020

Forward Genetic Approaches in Chlamydia trachomatis

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Area of Science:

Public Health
Infectious Diseases
Vaccinology

Background:

Chlamydia trachomatis is a leading communicable disease in North America and Europe.
Current control relies on screening and treatment, but this may hinder herd immunity development.
Rising reinfection rates are a significant public health concern.

Purpose of the Study:

To highlight the need for a Chlamydia trachomatis vaccine.
To discuss the challenges posed by current control strategies.
To propose a path forward for vaccine development.

Main Methods:

Review of Chlamydia vaccinomics research.
Analysis of the impact of screening and treatment on immunity.
Identification of potential subunit vaccine antigens.

Main Results:

Testing and treatment programs may inadvertently reduce the development of natural herd immunity.
Advances in vaccinomics have identified key Chlamydia trachomatis antigens for vaccine development.
A subunit vaccine approach is scientifically achievable.

Conclusions:

A Chlamydia trachomatis vaccine is crucial to overcome limitations of current control methods.
Accelerated vaccine development requires collaboration between academic, public health, and private sectors.
Prioritizing Chlamydia vaccine control globally is essential.